Most Medicare stroke patients rehospitalized or dead within year
American Heart Association rapid access journal report
2010-12-17
(Press-News.org) Nearly two-thirds of Medicare beneficiaries discharged from hospitals after ischemic stroke die or are readmitted within one year, researchers report in Stroke: Journal of the American Heart Association.
Stroke is the second leading cause of hospital admissions among older adults in the United States, according to American Heart Association/American Stroke Association statistics. Ischemic stroke, which occurs as a result of an obstruction within a blood vessel supplying blood to the brain, accounts for 87 percent of all strokes.
Only a few contemporary studies have examined the full burden of hospital readmission and death after ischemic stroke, said Gregg C. Fonarow, M.D., study lead author and professor of cardiovascular medicine at the University of California-Los Angeles.
Fonarow and colleagues studied ischemic stroke mortality and rehospitalization rates at 30 days and one year for Medicare beneficiaries and examined how those varied by hospital.
"We looked at readmission in addition to mortality because it is expensive to the healthcare system and may represent a potentially preventable, adverse event for patients," Fonarow said.
They analyzed outcome data from 91,134 Medicare beneficiaries treated at 625 hospitals participating in the American Heart Association/American Stroke Association's Get With The Guidelines®-Stroke initiative between April 2003 and December 2006.
"The Get With The Guidelines-Stroke database linked to Medicare data provided a very valuable opportunity to analyze outcomes for ischemic stroke patients from all regions of the country and from a broad group of acute care hospitals," said Fonarow, immediate past chair of the Get With The Guidelines Steering Committee. "Clinical data, coupled with long-term outcome data, was not previously available for Medicare beneficiaries at the national level."
The researchers found:
In-hospital death rates for ischemic stroke patients are nearly 15 percent within 30 days of admission and more than 30 percent within one year of admission.
The post discharge death or readmission rates are 61.9 percent within one year after discharge.
When ranked according to outcome – by death or rehospitalization rates – the 30-day death rate after admission for hospitals that were in the top performing was 9.8 percent, compared with 17.8 percent for the worst performing.
No improvements in death or rehospitalization rates for Medicare beneficiaries with acute stroke occurred from 2003 to 2006.
"These findings underscore the need for quality improvement interventions and systems of care that will improve early, intermediate, and long-term outcomes of patients with acute ischemic stroke," Fonarow said. "Standardizing evidence-based practices that focus on reducing the risks of preventable deaths or readmissions for ischemic stroke patients may be critical."
Findings from Get With The Guidelines-Stroke help define the frequency, timing and variation for hospital readmission. This should help clinicians, investigators and policymakers identify opportunities to apply targeted quality improvement and preventive strategies after ischemic stroke, Fonarow said. Participation in Get With The Guidelines-Stroke can assist hospitals with their stroke performance improvement efforts.
"Most of the variation in outcomes was unexplained by patient and hospital characteristics," Fonarow said. "This suggests that other factors, including treatment provided, systems of care, care transitions and outpatient follow-up, may explain much of the variation in outcomes."
A limitation of the study is that it includes only patients in fee-for-service Medicare and doesn't include patients enrolled in managed care, the uninsured and patients younger than 65.
INFORMATION:
Co-authors are: Eric E. Smith, M.D., M.P.H,; Mathew J. Reeves, Ph.D.; Wenqin Pan,
Ph.D.; DaiWai Olson, Ph.D.; Adrian F. Hernandez, M.D., M.H.S.; Eric D. Peterson, M.D., M.P.H.; and Lee H. Schwamm, M.D. Author disclosures are on the manuscript.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
NR10– 1188 (Stroke/Fonarow)
Additional Resources/Information:
Downloadable stock footage, animation,and our image gallery are located at www.heart.org/news under Multimedia.
For more information on Get With The Guidelines®, visit www.heart.org/quality.
Get With The Guidelines®–Stroke (GWTG-Stroke) is provided by the American Heart Association/American Stroke Association. The program is currently supported in part by a charitable contribution from Bristol-Myers Squib/Sanofi Pharmaceutical Partnership and the American Heart Association Pharmaceutical Roundtable. GWTG-Stroke has been funded in the past through support from Boeringher-Ingelheim and Merck.
ELSE PRESS RELEASES FROM THIS DATE:
2010-12-17
A UCLA-led has study found that after leaving the hospital, nearly two-thirds of Medicare beneficiaries hospitalized for acute ischemic stroke either died or were rehospitalized within a year.
The findings point to an opportunity for more quality-of-care initiatives to improve stroke care, especially in transitioning to home, stroke rehabilitation and outpatient care.
The study, which appears online Dec. 16 in Stroke, a journal of the American Heart Association, also found that hospital mortality and readmission rates varied widely nationwide, indicating there ...
2010-12-17
Researchers from Mount Sinai School of Medicine have found that when one copy of the SHANK3 gene in mice is missing, nerve cells do not effectively communicate and do not show cellular properties associated with normal learning. This discovery may explain how mutations affecting SHANK3 may lead to autism spectrum disorders (ASDs). The research is currently published in Molecular Autism.
"We know that SHANK3 mutation plays a central, causative role in some forms of autism spectrum disorders, but wanted to learn more about how it does this," said Joseph Buxbaum, PhD, Director ...
2010-12-17
CHAPEL HILL, N.C. – The function of histones -- the proteins that enable yards of DNA to be crammed into a single cell -- depends on a number of chemical tags adorning their exterior. This sophisticated chemical syntax for packaging DNA into tight little coils or unraveling it again -- called the "histone code" -- is the latest frontier for researchers bent on understanding how genetics encodes life.
But recent research from the University of North Carolina at Chapel Hill has found a number of issues with histone antibodies, the main tools used to decipher this code, ...
2010-12-17
A research team from the Institut Català de Nanotecnologia (ICN), in Barcelona, has demonstrated a device that induces electron spin motion without net electric currents, a key step in developing the spin computers of the future. The results are published in the Dec 17 issue of the journal Science. The authors are Marius V. Costache and Sergio O. Valenzuela, an ICREA Professor who is leader of the Physics and Engineering of Nanodevices Group at ICN.
Spintronics is a branch of electronics that aims to use the electron spin rather than its charge to transport and store ...
2010-12-17
The research project 'Older People's Use of Unfamiliar Space' (OPUS) examined the strategies used by older people to find their way in unfamiliar spaces as pedestrians and users of public transport. As part of the research, older people were shown town scenes and pedestrian routes and gave feedback on signposting, ease of navigation and general impressions. Their heart rates were measured to monitor stress levels. Participants were also taken to a town centre to walk through the same routes in person.
Initial findings show:
Signs are of limited use even in unfamiliar ...
2010-12-17
Scientists at the Johns Hopkins Kimmel Cancer Center have deciphered the genetic code for medulloblastoma, the most common pediatric brain cancer and a leading killer of children with cancer. The genetic "map" is believed to be the first reported of a pediatric cancer genome and is published online in the December 16 issue of Science Express.
Notably, the findings show that children with medulloblastoma have five- to tenfold fewer cancer-linked alterations in their genomes compared with their adult counterparts, the scientists say.
"These analyses clearly show that ...
2010-12-17
Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children. The large multicenter study defines the genetic landscape of this cancer, and holds intriguing clues to gene changes on signaling pathways that may become fruitful targets for future therapies.
The most common cancerous brain tumor in children, medulloblastoma is, fortunately, rare. However, it causes significant mortality, and survivors may suffer serious long-term side effects ...
2010-12-17
AMES, Iowa – Advancements in fabrication technologies may lead to superlenses and other designer optical materials, according to an Iowa State University and Ames Laboratory physicist.
In an article titled "Improving Metamaterials" published in the Perspectives section of the Dec. 17 issue of the journal Science, Costas Soukoulis and Martin Wegener write about the man-made materials designed to deliver certain properties not found in nature.
Soukoulis is an Iowa State University Distinguished Professor and Frances M. Craig Professor of Physics and Astronomy and a senior ...
2010-12-17
Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients. The high repeatability of RFA is advantageous in controlling recurrences of cancerous tumors in the liver. Results of this 10-year retrospective study are available in the January 2011 issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
HCC is the third leading cause of death from cancer worldwide and according to the ...
2010-12-17
In the war on cancer, perhaps there is nothing more powerful in a physician's arsenal than early detection. Despite recent advances in early detection and treatment, breast cancer remains a common and significant health problem in the United States and worldwide. Approximately one in ten women will get breast cancer in their lifetime and more than half of women with late stage cancer (II and III) have no cure or effective therapeutic available.
Using a new, powerful method for rapidly screening molecules associated with disease, proteomics expert Joshua LaBaer and colleagues ...
LAST 30 PRESS RELEASES:
[Press-News.org] Most Medicare stroke patients rehospitalized or dead within year
American Heart Association rapid access journal report